Table 1 Demographic and clinical characteristics of patients without and with PSD

 Age, median (IQR)

58(51, 66)

60(52, 67)

0.143

 Females, n (%)

82(19.50)

66(28.00)

0.013*

 BMI, median (IQR)

24.45(22.50, 26.90)

24.20(22.50,26.73)

0.387

 hospitalization days, median (IQR)

10(8, 13)

11(8, 15)

0.002*

 Sleep time < 5 h, n (%)

44(10.50)

45(19.1)

0.002*

 Education level, n (%)

189(45.00)

79(33.50)

0.004*

 Smoking, n (%)

190(45.20)

99(41.90)

0.415

 Drinking, n (%)

195(46.40)

93(39.40)

0.082

 Hypertension, n (%)

249(59.30)

136(57.60)

0.679

 Diabetes mellitus, n(%)

120(28.60)

67(28.40)

0.961

 Hyperlipemia, n (%)

106(25.20)

73(30.90)

0.116

 CHD, n (%)

43(10.20)

26(10.50)

0.755

 FCP, median (IQR)

1.82(1.14, 2, 49)

2.00(1.38, 2.70)

0.009*

 ACTH, median (IQR)

30.90(16.64, 44.43)

32.40(18.61,47.95)

0.229

 CRP, median (IQR)

1.80(0.80, 5.48)

2.50(0.93, 5.89)

0.087

 Cortical, median (IQR)

13.00(10.33, 15.70)

13.50(10.93,16.20)

0.077

 WBC, median (IQR)

6.57(5.39, 8.08)

6.89(5.66, 8.50)

0.037*

 NEU, median (IQR)

4.11(3.25, 5.46)

4.36(3.47, 5.80)

0.018*

 MONO, median (IQR)

0.50(0.39, 0.62)

0.53(0.44, 0.67)

0.006*

 LYM, median (IQR)

1.58(1.27, 2.09)

1.65(1.23, 1.99)

0.904

 IL.1β, median (IQR)

66.47(28.05, 165.07)

63.60(26.05,167.02)

0.894

 IL.6, median (IQR)

6.00(2.76,9.54)

6.00(2.60,10.06)

0.242

 IL.10, median (IQR)

9.13(2.89,22.96)

7.78(2.57,19.73)

0.286

 IL.18, median (IQR)

2158.84(1012.72,4753.75)

1896.82(954.22,4913.12)

0.439

 TNF-α, median (IQR)

37.11(21.85,57.62)

41.42(23.20,59.97)

0.260

 IFN-γ, median (IQR)

4.33(1.50,8.27)

5.10(2.00,9.72)

0.063

 NIHSS, median (IQR)

2(1,5)

3(2,7)

<0.001*

 BI, median (IQR)

95(65,100)

80(40,100)

<0.001*

 MRS, median (IQR)

2(1,3)

2(1,4)

0.002*

 CD-RISC, median (IQR)

65(54,77)

61(50,73)

0.008*

 N, median (IQR)

8(4,11)

9(6,13)

0.027*